CADL · Candel Therapeutics, Inc.
Market Cap
$1.00B
Shares
76.52M
Candel Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Candel Therapeutics, Inc. (CADL), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-08-12
Candel Therapeutics, Inc. (CADL) August 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Candel Therapeutics, Inc. (CADL) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-20
Candel Therapeutics, Inc. (CADL) Q1 2026 Earnings Call
Diluted EPS
$-0.14
▼ 207.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-05-15
Candel Therapeutics, Inc. (CADL) May 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-08-14
Candel Therapeutics, Inc. (CADL) Q2 2025 Earnings Call
Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q3
2022-11-10
Candel Therapeutics, Inc. (CADL) Q3 2022 Earnings Call
Revenue
$31,000
▲ 0% YoY Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts
CIK
1841387
CUSIP
137404109
13F (30d)
116 filings
116 filers
Visit website
Investor relations